Ngā hua rapu - Boris Rodenko

  • E whakaatu ana i te 1 - 7 hua o te 7
Whakamahine hua
  1. 1
    Ubiquitin‐Based Probes Prepared by Total Synthesis To Profile the Activity of Deubiquitinating Enzymes

    Ubiquitin‐Based Probes Prepared by Total Synthesis To Profile the Activity of Deubiquitinating Enzymes mā Annemieke de Jong, Remco Merkx, Ilana Berlin, Boris Rodenko, Ruud H. Wijdeven, Dris El Atmioui, Zeliha Yalçin, Craig Robson, Jacques Neefjes, Huib Ovaa

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules

    Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules mā Celia R. Berkers, Annemieke de Jong, Karianne Schuurman, Carsten Linnemann, Hugo D. Meiring, Lennert Janssen, Jacques Neefjes, Ton N. Schumacher, Boris Rodenko, Huib Ovaa

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Essential roles for deubiquitination in Leishmania life cycle progression

    Essential roles for deubiquitination in Leishmania life cycle progression mā Andreas Damianou, Rebecca J. Burge, Carolina Moura Costa Catta‐Preta, Vincent Geoghegan, Y. Romina Nievas, Katherine Newling, Elaine Brown, Richard Burchmore, Boris Rodenko, Jeremy C. Mottram

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7

    Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 mā Arne Bakker, Rieuwert Hoppes, Carsten Linnemann, Mireille Toebes, Boris Rodenko, Celia R. Berkers, Sine Reker Hadrup, Wim J.E. van Esch, Mirjam H.M. Heemskerk, Huib Ovaa, Ton N. Schumacher

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Proteasome Activation by Small Molecules

    Proteasome Activation by Small Molecules mā Yves Leestemaker, Annemieke de Jong, Katharina F. Witting, Renske Penning, Karianne Schuurman, Boris Rodenko, Esther A. Zaal, Bert van de Kooij, Stefan Laufer, Albert J. R. Heck, Jannie Borst, Wiep Scheper, Celia R. Berkers, Huib Ovaa

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2–Restricted T Cell Epitopes

    Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2–Restricted T Cell Epitopes mā Rieuwert Hoppes, Rimke Oostvogels, Jolien J. Luimstra, Kim Wals, Mireille Toebes, Laura Bies, Reggy Ekkebus, Pramila Rijal, Patrick H. N. Celie, Julie H. Huang, Maarten E. Emmelot, Robbert M. Spaapen, Henk M. Lokhorst, Ton N. Schumacher, Tuna Mutis, Boris Rodenko, Huib Ovaa

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis

    Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis mā Christophe Desmet, Tristan Gallenne, Alexandre Prieur, Fabien Reyal, Nils L. Visser, Ben S. Wittner, Marjon A. Smit, Thomas R. Geiger, Jamila Laoukili, Sedef Iskit, Boris Rodenko, Wilbert Zwart, Bastiaan Evers, Hugo M. Horlings, Abderrahrim Ajouaou, John Zevenhoven, M. van Vliet, Sridhar Ramaswamy, Lodewyk F.A. Wessels, Daniel S. Peeper

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: